GH News - Candlesense

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on July 22, 2025, the Compensation Committee of Guardant’s Board o...

What is the historical price reaction to similar employee compensation announcements for Guardant Health and its industry peers? Are there any tax or accounting implications associated with the RSU and NQSO grants that could affect cash flow or balance‑sheet metrics? How might the compensation committee’s approval of these awards affect analyst sentiment and target price revisions for Guardant Health?

Compensation

8 days ago

American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity

SAN FRANCISCO--(BUSINESS WIRE)---- $GH--The American Cancer Society (ACS) today announced a new partnership with Guardant Health (Nasdaq: GH), a leading precision oncology company focused on improv...

Could the partnership lead to new data sets or collaborations that enhance Guardant Health's proprietary technology and patents? What is the expected timeline for measurable health‑equity outcomes and how will those be reported to investors? How does the partnership align with Guardant Health's long‑term strategic roadmap and product pipeline?

Partnership

20 days ago

Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been na...

Awards

2 months ago